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OBJECTIVEdTo establish the incidence of nontraumatic lower-extremity amputation (LEA)
in people with diabetes in Scotland.
RESEARCH DESIGN AND METHODSdThis cohort study linked national morbidity
records and diabetes datasets to establish the number of people with diabetes who underwent
nontraumatic major and minor LEA in Scotland from 2004 to 2008.
RESULTSdTwo thousand three hundred eighty-two individuals with diabetes underwent a
nontraumatic LEA between 2004 and 2008; 57.1% (n = 1,359) underwent major LEAs. The
incidence of any LEA among persons with diabetes fell over the 5-year study period by 29.8%
(3.04 per 1,000 in 2004 to 2.13 per 1,000 in 2008, P , 0.001). Major LEA rates decreased by
40.7% from 1.87 per 1,000 in 2004 to 1.11 per 1,000 in 2008 (P , 0.001).
CONCLUSIONSdThere has been a signiﬁcant reduction in the incidence of LEA in persons
with diabetes in Scotland between 2004 and 2008, principally explained by a reduction in major
amputation.
Diabetes Care 35:2588–2590, 2012
D iabetes-related foot disease resultsin major morbidity and morta-lity (1). National and global am-
putation rates vary considerably (2,3)
because of confounding factors,
such as ethnicity, case deﬁnition, and
ascertainment of diabetes prevalence (4).
The aim of this study was to establish any
change in the incidence of diabetes-
related nontraumatic lower-extremity
amputation (LEA) in Scotland from 2004
to 2008.
RESEARCH DESIGN AND
METHODSdWe performed a cohort
study of all people in Scotlandwith diabetes
between January 2004 and December
2008. The Scottish Morbidity Record was
the primary data source using predeﬁned
codes for categorization of amputation type
(OCPS-4 codes 307–11). This was linked
with the ScottishCare Information–Diabetes
Collaboration (SCI-DC) National Diabetes
Register (5).
Approval for the dataset was from
SCI-DC, Scottish multicenter research
ethics committee, Privacy Advisory Com-
mittee of NHSNational Services Scotland,
and Caldicott guardians.
An LEA was deﬁned as a complete
loss in the transverse anatomical plane of
any part of the limb. Major amputation
was any through or proximal to the ankle
and minor distal to the ankle. In patients
with more than one procedure, the high-
est level of amputation was analyzed.
Traumatic and tumor-related amputa-
tions were excluded. A diabetes-related
LEA was any in a person known to have
diabetes at the time of amputation or
registered with diabetes within 3 months
of amputation.
The national population was taken
from the General Register Ofﬁce for Scot-
land’s midpoint population estimates.
The diabetes population was taken from
SCI-DC. Incidence of amputation was ex-
pressed as number of amputations in peo-
ple with diabetes per 1,000 individuals
with diabetes and per 100,000 general
population.
Chi-square test methods were used to
assess changes in amputations over time.
The signiﬁcances of linear trends were
investigated using Kendall tb. This cohort
study has been reported using Strength-
ening the Reporting of Observational
Studies in Epidemiology guidance (6).
RESULTSdThe Scottish diabetes pop-
ulation increased by 12.8% from 183,311
in 2004 to 206,818 in 2008. This repre-
sents an increase in crude prevalence of
diabetes from 3.6 to 4.0%. The mean age
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of people with diabetes increased from
59.4 to 62.7 years from 2004 to 2008.
Diabetes duration increased from 7.6 to
8.7 years over 5 years. Other parameters
including HbA1c, BMI, and estimated glo-
merular ﬁltration rate remained stable.
Two thousand three hundred eighty-
two people with diabetes underwent non-
traumatic LEAs between 2004 and 2008.
The number of people undergoing major
and minor amputations over 5 years were
1,359 and 1,023, respectively (Table 1).
This corresponded to a total, major, and
minor amputation rate of 2.42, 1.39, and
1.04 per 1,000 individuals with diabetes
per year, respectively.
The incidence of major and total
amputations (per 1,000 of the diabetes
population) fell steadily over 5 years (P,
0.001). There was a 29.8% reduction in
individuals with diabetes undergoing any
LEA from 3.04 to 2.13 per 1,000. The
most pronounced fall was in major
LEAs, with a reduction of 40.7% from
1.87 per 1,000 in 2004 to 1.11 per
1,000 in 2008. There was a 1.7-fold vari-
ation in diabetes-related amputation rates
between different health boards (range
1.1–1.9%, P , 0.001).
The incidence of diabetes-related am-
putations per 100,000 of the general
population fell by 22.2% from 10.97 to
8.53. The decreasing trend was statisti-
cally signiﬁcant for major and total (P ,
0.001 in both cases) but not minor ampu-
tations. The largest fall was in those un-
dergoing major LEAs, in which there
was a reduction of 34.2% from 6.73 to
4.43 per 100,000 from 2004 to 2008.
CONCLUSIONSdThe incidence of
LEA in persons with diabetes in Scotland
has decreased by 30% over 5 years. The
greatest reduction was in major amputa-
tion, which fell by 41%.
A potential confounding factor con-
tributing to the decreased incidence of
amputations in our study could be im-
proved registration of diabetes rather than a
true increase in the prevalence of new cases.
Establishing accurate amputation inci-
dence is difﬁcult because of variability in
the denominator and misclassiﬁcation of
cases (7). Although it is important to con-
sider case ascertainment, it is unlikely to
be a major factor in our study because the
Scottish information system for diabetes di-
agnosis has been established for a number
of years, and the annual increase in preva-
lence of 0.2% indicates an established sta-
ble population.
Because amputation rates are suscepti-
ble to many confounding variables, it has
been suggested that to demonstrate a gen-
uine improvement both incidence and
absolute number of amputations should
fall (4). We have shown both to be the case
and feel that the decrease in amputation
rate is therefore genuine. Several regional
studies have demonstrated signiﬁcant re-
ductions in diabetes-related amputations
(8–10); however, this is not reﬂected at a
national level (11,12). Further studies have
shown signiﬁcant geographic variation
within countries (13) and highlight the
beneﬁt of national data in determining ac-
curate amputation rates.
Countries that have shown a reduction
in diabetes-related amputations include the
Netherlands (2), Finland (14), and the U.S.
(15), with a decrease in total amputations
of 37, 49, and 65%, respectively. These
studies were hampered with methodologi-
cal problems, including estimates from a
projected diabetes population, failure to
provide the incidence for amputation sub-
types, and reporting relative risk compared
with nondiabetic subjects. This raises the
possibility that a signiﬁcant proportion of
any decrease was a result of diabetes case
ascertainment or an increased rate of am-
putation in people without diabetes. These
studies highlight the problems of compar-
ing amputation rates when the number of
subjects in the denominator changes signif-
icantly or there is failure to report transpar-
ent data on amputation types. There is an
urgent need to devise a consistent approach
to reporting amputation incidence. Similar
to others (4), we would advocate that total,
major, and minor amputation incidences
are reported per 1,000 subjects with diabe-
tes and per 100,000 of the general popula-
tion. This would allow comparisons
between countries, and inclusion of general
population rates helps negate any numera-
tor/denominator bias relating to identiﬁca-
tion of diabetes cases.
We believe that Scotland is the fourth
nation to show a signiﬁcant reduction in
the incidence of diabetes-related LEAs.
However, Scotland is the ﬁrst to provide
information on amputation subtypes and
rates from an actual rather than estimated
diabetes population.
AcknowledgmentsdThese data were avail-
able for analysis by members of the Scottish
Table 1dMinor, major, and total amputations and incidence in the diabetes and general population in Scotland from 2004 to 2008
Amputations (95% CI)
Year Minor Major Total
Amputations 2004 215 342 557
2005 218 258 476
2006 192 270 462
2007 186 260 446
2008 212 229 441
Incidence (1,000 of diabetes population) 2004 1.17 (1.03, 1.34) 1.87 (1.68, 2.07) 3.04 (2.80, 3.30)
2005 1.13 (0.99, 1.29) 1.34 (1.19, 1.51) 2.47 (2.26, 2.70)
2006 0.96 (0.83, 1.10) 1.35 (1.20, 1.52) 2.30 (2.11, 2.53)
2007 0.90 (0.78, 1.04) 1.26 (1.12, 1.42) 2.16 (1.97, 2.37)
2008 1.03 (0.90, 1.17) 1.11 (0.99, 1.26) 2.13 (1.94, 2.34)
Incidence (100,000 of general population) 2004 4.23 (3.70, 4.84) 6.73 (6.06, 7.49) 10.97 (10.09, 11.92)
2005 4.28 (3.75, 4.89) 5.06 (4.48, 5.72) 9.34 (8.24, 9.89)
2006 3.75 (3.26, 4.32) 5.28 (4.68, 5.94) 9.03 (8.24, 9.89)
2007 3.62 (3.13, 4.17) 5.05 (4.48, 5.71) 8.67 (7.90, 9.51)
2008 4.10 (3.59, 4.69) 4.43 (3.89, 5.04) 8.53 (7.77, 9.37)
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